Barclays lowered the firm’s price target on Revvity to $92 from $120 and keeps an Equal Weight rating on the shares. The company reported a miss across the board but Q4 “appears de-risked” at the low end of new guidance, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RVTY: